Neue Suche | Kongressdetail
Druckansicht
 
 

Anti-Fibrotic Drug Development Summit (AFDD)

evvnt Platform / evvnt
-
13.11.2017 - 14.11.2017  Hyatt Regency Boston, One Avenue de Lafayette, 02111 Boston, USA
Time: 8:20 am to 3:45 pm.
 
Kongressthemen
This Anti-Fibrotic Drug Development conference will be a unique opportunity for drug developers focused on organ-specific indications to participate in a cross-disciplinary, multi-organ discussions in order to gain new insights into their anti-fibrotic drug development research.

Attending this comprehensive forum will enable you to; identify which fibrotic mechanisms are driving pathology changes in humans; effectively translate from preclinical to clinical development.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Ray Jupp (UCB), Richard Marshall (GSK), Lisa Hazelwood (AbbVie), Peter Blume-Jensen (Xtuit Pharmaceuticals), Alexey Lugovskoy (Morphic Therapeutics), Seth Porter (FibroGen)
 

Anfragen und Anmeldung:

https://go.evvnt.com/147139-2
Herr Customer Services
44 020 3141 8700
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
USD 2.699,00
(Register by August 18 to save $300: USD 2399, Register by September 8 to save $200: USD 2499, Register by October 6 to save $100: USD 2599, Standard Rate: USD 2699.)
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
Tel: +44 0207 3230 450
hello@evvnt.com
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Center of ExcellenceSwiss Tropical and Public Health InstitutenewTreeÖsterreichische Gesellschaft für Public HealthHelix - Forschung & Beratung WienÄrzte der WeltFFG - 7. EU-RahmenprogrammThe European Public Health Association (EUPHA)

Facebook